Literature DB >> 9586879

Vascular enumeration as a significant prognosticator for invasive breast carcinoma.

M J Aceñero1, J F González, M G Gallego, P A Ballesteros.   

Abstract

PURPOSE: Vascular enumeration has been claimed to be an independent prognosticator for invasive breast cancer. Most of the studies have performed a manual count of the vessels. Few investigators have used image analyzers to reduce subjectivity in the measures. The aim of this retrospective study was to compare the manual vessel count to the counts obtained with an image analyzer and to estimate their possible prognostic influence.
MATERIALS AND METHODS: We selected 112 patients with invasive ductal carcinoma, treated with radical mastectomy followed by chemotherapy and with a minimal follow-up time of 60 months (5 years). After immunostaining with factor VIII, we performed a double count of the vessels. First, we performed a manual count following Gasparini's criteria, and second, we used an image analyzer (Microm, Barcelona, Spain) to count the vessels in eight adjacent microscopic fields with a 20x objective, to reach a total area of 0.98 mm2. The image analyzer calculated the total number of vessels, their size and also the percentage of the field occupied by the vessels.
RESULTS: In our series, vascular enumeration showed no significant association with histologic grade (Bloom-Scarff-Richardson grading), tumor size, or staging.
CONCLUSION: Vascular enumeration with both methods was an independent prognosticator for relapse-free-survival (RFS) in both node-negative and -positive patients in the univariate analysis, but only vascular enumeration with the image analyzer was an independent prognostic factor in the multivariate analysis, together with lymph node metastases.

Entities:  

Mesh:

Year:  1998        PMID: 9586879     DOI: 10.1200/JCO.1998.16.5.1684

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  9 in total

1.  Obesity and microvascular invasion in hepatocellular carcinoma.

Authors:  Abby B Siegel; Shuang Wang; Judith S Jacobson; Dawn L Hershman; Emerson A Lim; Jeanette Yu; Lauren Ferrante; Kalpana M Devaraj; Helen Remotti; Shannon Scrudato; Karim Halazun; Jean Emond; Lorna Dove; Robert S Brown; Alfred I Neugut
Journal:  Cancer Invest       Date:  2010-12       Impact factor: 2.176

2.  Tumor angiogenesis and its clinical significance in pediatric malignant liver tumor.

Authors:  Xiao-Yi Sun; Zai-De Wu; Xiao-Feng Liao; Ji-Yan Yuan
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

3.  Bone marrow angiogenesis and its correlation with other disease characteristics in multiple myeloma in stage I versus stage II-III.

Authors:  Kathrin Niemöller; Christian Jakob; Ulrike Heider; Ivana Zavrski; Jan Eucker; Olaf Kaufmann; Kurt Possinger; Orhan Sezer
Journal:  J Cancer Res Clin Oncol       Date:  2003-04-17       Impact factor: 4.553

4.  Histopathological subclassification of triple negative breast cancer using prognostic scoring system: five variables as candidates.

Authors:  Minoru Miyashita; Takanori Ishida; Kazuyuki Ishida; Kentaro Tamaki; Masakazu Amari; Mika Watanabe; Noriaki Ohuchi; Hironobu Sasano
Journal:  Virchows Arch       Date:  2010-11-21       Impact factor: 4.064

Review 5.  Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches.

Authors:  Ronnie Tung-Ping Poon; Sheung-Tat Fan; John Wong
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

6.  The relation between bone marrow angiogenesis and the proliferation index Ki-67 in multiple myeloma.

Authors:  M G Alexandrakis; F H Passam; C Dambaki; C A Pappa; E N Stathopoulos
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

7.  Comparison of microvessel density before and after peripheral blood stem cell transplantation in multiple myeloma patients and its clinical implications: multicenter trial.

Authors:  Ho Suk Oh; Jung-Hae Choi; Chan Keum Park; Chul Won Jung; Soon Il Lee; Quehn Park; Cheolwon Suh; Sung-Bae Kim; Hyun Sook Chi; Jae Hoon Lee; Eun Kyung Cho; Soo-Mee Bang; Myung-Ju Ahn
Journal:  Int J Hematol       Date:  2002-12       Impact factor: 2.490

Review 8.  Clinical implications of angiogenesis in cancers.

Authors:  Roberta W C Pang; Ronnie T P Poon
Journal:  Vasc Health Risk Manag       Date:  2006

9.  Angiogenesis in myelodysplastic syndromes.

Authors:  G Pruneri; F Bertolini; D Soligo; N Carboni; A Cortelezzi; P F Ferrucci; R Buffa; G Lambertenghi-Deliliers; F Pezzella
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.